Rasbach Kyle bought LXEO
January 17, 2025 · Form 4 insider transaction
Rasbach Kyle bought 40,875 shares of Lexeo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,875
Price
$0.00
Total value
N/A
InsiderRasbach Kyle
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 17, 2025
Filing dateJanuary 22, 2025
Shares owned after40,875
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.; The reported securities are RSUs.